File Download
Patent History
- ApplicationCN 20098116060 2009-04-16
- PublicationCN 102026655 2011-04-20
Patent Family
Supplementary
-
Citations:
- Appears in Collections:
published patent: Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks
Title | Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks |
---|---|
Priority Date | 2009-04-16 PCT/CN2009000405 2008-04-30 US 12/113056 |
Inventors | |
Issue Date | 2011 |
Citation | China Published Patent Application CN 102026655. Beijing, PRC: State Intellectual Property Office (SIPO) of the P.R.C., 2011 How to Cite? |
Abstract | Methods and apparatus are disclosed for the measurement of lipocalin-2 in body fluid (including but not limited to blood, serum, plasma, urine, saliva, tear, etc) by an assay such as a immunoassay or an immunotest for (1) the prediction of risk of future cardiovascular diseases and (2) the determination of the likelihood that certain individuals will benefit to a greater o lesser extent from the use of certain treatments designed to prevent and/or treat cardiovascula diseases. |
Persistent Identifier | http://hdl.handle.net/10722/176636 |
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2012-11-30T08:38:17Z | - |
dc.date.available | 2012-11-30T08:38:17Z | - |
dc.date.issued | 2011 | - |
dc.identifier.citation | China Published Patent Application CN 102026655. Beijing, PRC: State Intellectual Property Office (SIPO) of the P.R.C., 2011 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/176636 | - |
dc.description.abstract | Methods and apparatus are disclosed for the measurement of lipocalin-2 in body fluid (including but not limited to blood, serum, plasma, urine, saliva, tear, etc) by an assay such as a immunoassay or an immunotest for (1) the prediction of risk of future cardiovascular diseases and (2) the determination of the likelihood that certain individuals will benefit to a greater o lesser extent from the use of certain treatments designed to prevent and/or treat cardiovascula diseases. | en_HK |
dc.title | Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks | en_HK |
dc.type | Patent | en_US |
dc.description.nature | published_or_final_version | en_US |
dc.contributor.inventor | Xu, A | en_HK |
dc.contributor.inventor | Wang, Y | en_HK |
dc.contributor.inventor | Renneberg Reinhard | en_HK |
dc.contributor.inventor | Cautherley, GWH | en_HK |
dc.contributor.inventor | Chan, CPY | en_HK |
dc.contributor.inventor | Lehmann, M | - |
patents.identifier.application | CN 20098116060 | en_HK |
patents.description.assignee | VERSITECH LTD; R & C BIOGENIUS LTD | en_HK |
patents.description.country | China, PRC | en_HK |
patents.date.publication | 2011-04-20 | en_HK |
patents.date.application | 2009-04-16 | en_HK |
patents.date.priority | 2009-04-16 PCT/CN2009000405 | en_HK |
patents.date.priority | 2008-04-30 US 12/113056 | en_HK |
patents.description.cc | CN | en_HK |
patents.identifier.publication | CN 102026655 | en_HK |
patents.relation.family | CN 102026655 (A) 2011-04-20 | en_HK |
patents.relation.family | EP 2300048 (A1) 2011-03-30 | en_HK |
patents.relation.family | JP 2011519037 (A) 2011-06-30 | en_HK |
patents.relation.family | US 2009274709 (A1) 2009-11-05 | en_HK |
patents.relation.family | US 8030097 (B2) 2011-10-04 | en_HK |
patents.relation.family | WO 2009132510 (A1) 2009-11-05 | en_HK |
patents.description.kind | A | en_HK |
patents.type | Patent_published | en_HK |